The Characteristics of Pediatric Patients with Familial Mediterranean Fever Treated with Anti-Interleukin-1 Treatment
TURKISH ARCHIVES OF PEDIATRICS, cilt.57, sa.4, ss.448-452, 2022 (ESCI, Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 57 Sayı: 4
- Basım Tarihi: 2022
- Doi Numarası: 10.5152/turkarchpediatr.2022.22039
- Dergi Adı: TURKISH ARCHIVES OF PEDIATRICS
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.448-452
- Anahtar Kelimeler: Anakinra, canakinumab, familial Mediterranean fever, IL-1 inhibitors, pediatrics, ACUTE-PHASE RESPONSE, COLCHICINE, ACTIVATION, MUTATIONS
- Ankara Üniversitesi Adresli: Evet
Özet
Objective: Interleukin-1 inhibitors are effective agents used in colchicine resistance or intolerance during the treatment of familial Mediterranean fever. This study aims to review the characteristics of patients treated with interleukin-1 inhibitors and their long-term follow-up in a large pediatric cohort of familial Mediterranean fever patients.